Jeffrey Carter, MD*
Atrial fibrillation (AF), a cardiac complication following non-cardiothoracic surgery, is more common and better characterized following cardiac surgery. Postoperative AF often prompts surgeons to consult hospitalists because it can be associated with serious surgical complications such as sepsis and venous thromboembolism. Although typically self-limited, AF can persist to discharge and can lead to an increased length of stay. Furthermore, conditions that are associated with AF contribute to increased mortality. The following module addresses the frequency and risk factors for AF, initial management and evaluation of postoperative AF, and the management of persistent postoperative AF that is still present at discharge.
After completing the module, the participant should be able to:
- Recognize the incidence and identify the risk factors for atrial fibrillation (AF) following noncardiac surgery.
- Propose management plans for postoperative AF.
- Identify and evaluate for underlying conditions associated with postoperative AF.
- Describe the impact of postoperative AF.
- Propose management plans for persistent postoperative AF.
The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.
Credit Designation Statement: The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Release date: December 1, 2009. Expiration date: December 1, 2011.
*Assistant Professor of Medicine, Director, Medicine Consult Service, University of Colorado Denver School of Medicine, Denver, Colorado.
Disclaimer: The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of The Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
Supported by an educational grant from Merck & Co., Inc.
Print
Email
Bookmark us!